NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 27 August 2009

Lonza reiterates Patheon bid

Lonza reiterated its bid for Patheon as JLL allowed its offer to expire. JLL holds 57% of Patheon. Lonza has bid $3.55/share for the company and will only proceed with an offer if it can secure 67%.
Wall Street Journal

No comments: